C-Rad AB (publ) (LON:0R44)

Market Cap	82.37M
Revenue (ttm)	33.85M
Net Income (ttm)	4.07M
Shares Out	n/a
EPS (ttm)	0.12
PE Ratio	20.22
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Average Volume	5,630
Open	29.85
Previous Close	n/a
Day's Range	29.85 - 29.85
52-Week Range	2.21 - 3.79
Beta	1.20
RSI	36.14
Earnings Date	May 7, 2025

About C-Rad AB

C-Rad AB (publ) develops, manufactures, and sells products and systems with applications in radiotherapy for the treatment of cancer in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company’s products include Sentinel 4DCT, a laser-based optical surface scanning system; Catalyst+ HD, a patient positioning, intra-fraction motion management, and respiratory gating solution for conventional and stereotactic treatment delivery; Catalyst+, a solution for patient set up and intra-fraction breath hold reproducibility; Cataly...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2004
• Employees: 99
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0R44

Financial Performance

In 2024, C-Rad AB's revenue was 469.00 million, an increase of 10.45% compared to the previous year's 424.62 million. Earnings were 56.45 million, an increase of 58.88%.

Financial numbers in SEK